Shanghai Sanyou Medical Co. Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000040J7
CNY
19.34
1.01 (5.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
538.97
450.45
456.69
642.42
588.13
387.65
351.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
538.97
450.45
456.69
642.42
588.13
387.65
351.83
Raw Material Cost
165.66
158.76
107.99
76.89
66.90
42.34
35.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
161.65
144.33
100.43
93.87
84.65
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.06
2.53
0.49
0.29
0.24
0.05
0.00
Selling and Distribution Expenses
228.04
194.85
176.31
329.45
319.28
202.52
193.56
Other Expenses
-9.13
-7.33
-4.29
-3.98
-3.24
3.08
1.61
Total Expenditure (Excl Depreciation)
467.11
427.14
342.32
460.69
438.65
275.75
244.72
Operating Profit (PBDIT) excl Other Income
71.9
23.3
114.39999999999999
181.70000000000002
149.5
111.89999999999999
107.10000000000001
Other Income
27.04
29.57
41.83
33.95
49.29
30.94
11.78
Operating Profit (PBDIT)
136.84
96.88
197.71
241.34
218.40
156.36
126.10
Interest
3.06
2.53
0.49
0.29
0.24
0.05
0.00
Exceptional Items
-12.84
-6.04
15.81
36.32
27.33
0.00
-0.04
Gross Profit (PBDT)
373.30
291.69
348.70
565.52
521.23
345.31
316.79
Depreciation
59.69
61.42
54.38
34.22
28.14
19.37
12.10
Profit Before Tax
61.25
26.89
158.65
243.15
217.35
136.95
113.96
Tax
10.32
9.79
21.23
35.99
22.18
18.39
15.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
63.10
11.47
95.58
190.82
186.37
118.56
97.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
63.10
11.47
95.58
190.82
186.37
118.56
97.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-18.21
0.64
18.06
12.74
8.78
0.00
0.24
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.89
12.11
113.64
203.56
195.15
118.56
98.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,104.78
1,911.80
1,916.19
1,839.74
1,685.85
1,534.12
437.81
Earnings per share (EPS)
0.19
0.04
0.32
0.64
0.63
0.4
0.33
Diluted Earnings per share
0.19
0.04
0.32
0.64
0.63
0.4
0.33
Operating Profit Margin (Excl OI)
9.3%
1.31%
22.22%
26.96%
23.97%
27.36%
29.05%
Gross Profit Margin
22.44%
19.6%
46.65%
43.18%
41.74%
40.32%
35.83%
PAT Margin
11.71%
2.55%
20.93%
29.7%
31.69%
30.58%
27.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 19.64% vs -1.36% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 271.07% vs -89.35% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 63.15% vs -56.83% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 24.00% vs 400.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Shanghai Sanyou Medical Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
538.97
0
538.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
538.97
0
538.97
Raw Material Cost
165.66
0
165.66
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
161.65
0
161.65
Power Cost
0
0
0.00
Manufacturing Expenses
3.06
0
3.06
Selling and Distribution Expenses
228.04
0
228.04
Other Expenses
-9.13
0.00
-9.13
Total Expenditure (Excl Depreciation)
467.11
0
467.11
Operating Profit (PBDIT) excl Other Income
71.86
0.00
71.86
Other Income
27.04
0
27.04
Operating Profit (PBDIT)
136.84
0
136.84
Interest
3.06
0
3.06
Exceptional Items
-12.84
0
-12.84
Gross Profit (PBDT)
373.30
0
373.30
Depreciation
59.69
0
59.69
Profit Before Tax
61.25
0
61.25
Tax
10.32
0
10.32
Provisions and contingencies
0
0
0.00
Profit After Tax
63.10
0
63.10
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
63.10
0
63.10
Share in Profit of Associates
0
0
0.00
Minority Interest
-18.21
0
-18.21
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.89
0
44.89
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,104.78
0
2,104.78
Earnings per share (EPS)
0.19
0
0.19
Diluted Earnings per share
0.19
0
0.19
Operating Profit Margin (Excl OI)
9.30%
0%
0.00
9.30%
Gross Profit Margin
22.44%
0%
0.00
22.44%
PAT Margin
11.71%
0%
0.00
11.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 53.90 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 19.64% vs -1.36% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 4.49 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 271.07% vs -89.35% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.98 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 63.15% vs -56.83% in Dec 2024

Annual - Interest
Interest 0.31 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 24.00% vs 400.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.30%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024